Effectiveness and Safety of TachoSil® Fibrin Sealant Patch for Supporting Dural Sealing Among Adult Inpatients
Condition(s) studied
Investigational drug(s) / intervention(s)
TachoSil®: TachoSil® is an absorbable fibrin sealant patch consisting of equine collagen coated with human fibrinogen and thrombin.
DuraSeal®: DuraSeal® sealants are polyethylene glycol (PEG) based hydrogel.
Study summary
This retrospective observational cohort study compares the effectiveness and safety of adjunctive TachoSil® fibrin sealant patch with DuraSeal® hydrogel sealant for supporting dural sealing in adult patients undergoing cranial or spinal surgery at participating United States hospitals. Medical records will be reviewed to assess clinically evident cerebrospinal fluid leak or clinically evident pseudomeningocele within 90 days after surgery. The study will use 1:1 propensity score matching to evaluate whether TachoSil® is non-inferior to DuraSeal® and will assess additional effectiveness and safety outcomes.
Eligibility
Primary outcome measure(s)
- Risk of Clinically Evident CSF Leak or Clinically Evident Pseudomeningocele — Within 90 days post surgery
A clinically evident CSF leak is defined as clear fluid leaking through the surgical incision or orifice verified by a glucose concentration test or β-2 transferrin test. A clinically evident pseudomeningocele is defined as a subcutaneous visible and/or palpable fluid accumulation adjacent to or at the site of surgical incision suspected to be CSF. If there is not a collection of CSF/pseudomeningocele, or active leak that can be sampled for β-2 transferrin test, but the participant had symptoms consistent with intracranial hypotension and/or an ex vacuo type subdural hematoma, the participant will be considered as having clinically evident CSF leak or pseudomeningocele.
Trial sites (6)
| Facility | City | Region | Status |
|---|---|---|---|
| Johns Hopkins University | Baltimore | Maryland | Recruiting |
| Columbia University | New York | New York | Recruiting |
| University of Cincinnati College of Medicine | Cincinnati | Ohio | Recruiting |
| Thomas Jefferson University | Philadelphia | Pennsylvania | Recruiting |
| Alleghany Health Network | Pittsburgh | Pennsylvania | Recruiting |
| Swedish Health Services | Seattle | Washington | Recruiting |
More Corza Medical GmbH trials in the USA
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07927413 on ClinicalTrials.gov ↗ ← All trials in the USA